306 Publications (Page 8 of 13)
2005
A Randomized, Double-Blind, Placebo-Controlled Trial of Two Doses of Ginkgo Biloba Extract in Dementia of the Alzheimer's Type
Schneider, Lon S⋅LS, Schneider⋅ST, DeKosky⋅Dekosky, Steven T⋅Farlow, Martin R⋅MR, Farlow⋅PN, Tariot⋅Tariot, Pierre N⋅Hoerr, Robert⋅R, Hoerr⋅M, Kieser and Kieser, Meinhard
Current Alzheimer Research, vol. 2, (no. 5), pp. 541-551, 2005. | Journal Article
 
Caffeic acid phenethyl ester possesses potent cardioprotective effects in a rabbit model of acute myocardial ischemia-reperfusion injury.
Tan, Jiangning⋅Ma, Zhizhong⋅Han, Ling⋅Du, Ruyu⋅Zhao, Liming⋅Wei, Xing⋅Hou, Dongming⋅Johnstone, Brian⋅Farlow, Martin R and Du, Yansheng
American journal of physiology. Heart and circulatory physiology, vol. 289, (no. 5), pp. H2265-71, 2005/Nov. | Journal Article
 
Cholinesterase inhibitors across stages of dementia and cognitive impairments in the elderly
GT Grossberg⋅S Borson⋅DI Kaufer and Farlow, Martin R
Annals of Long-Term Care: Clinical Care and Aging, vol. Supp, (no. July), pp. 1-8, 2005. | Journal Article
 
Efficacy of rivastigmine in Alzheimer's disease patients with rapid disease progression: Results of a meta-analysis
Farlow, Martin R⋅GW Small⋅Small, Gary⋅Quarg, Peter⋅P Quarg⋅Krause, Andreas and A Krause
Dementia and Geriatric Cognitive Disorders, vol. 20, pp. 192-197, 2005. | Journal Article
 
Efficacy of Rivastigmine in Alzheimer's Disease Patients with Rapid Disease Progression: Results of a Meta-Analysis
Farlow, Martin R⋅Small, Gary W⋅Quarg, Peter and Krause, Andreas
Dementia and Geriatric Cognitive Disorders, vol. 20, (no. 2-3), pp. 192-197, 2005. | Journal Article
 
Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease
Lane, Roger and Farlow, Martin
Journal of Lipid Research, vol. 46, (no. 5), pp. 968, 20050501. | Journal Article
 
Minocycline prevents gentamicin-induced ototoxicity by inhibiting p38 MAP kinase phosphorylation and caspase 3 activation
Wei, X.⋅Zhao, L.⋅Liu, J.⋅Dodel, RC⋅Farlow, Martin R and Du, Yansheng
Neuroscience, vol. 131, (no. 2), pp. 513-521, 2005. | Journal Article
 
Moderate to severe Alzheimer disease: definition and clinical relevance
Farlow, Martin R
Neurology, vol. 65, (no. 3), pp. S1-S4, 2005. | Journal Article
 
NF-(kappa)B mediates amyloid beta peptide-stimulated activity of the human apolipoprotein E gene promoter in human astroglial cells.
Du, Yansheng⋅Chen, Xianming⋅Wei, Xing⋅Bales, Kelly R⋅Berg, David T⋅Paul, Steven M⋅Farlow, Martin R⋅Maloney, Bryan⋅Ge, Yuan-Wen and Lahiri, Debomoy K
Brain research. Molecular brain research, vol. 136, (no. 1-2), pp. 177-88, 2005/May/20. | Journal Article
 
NF- mu B mediates amyloid beta peptide-stimulated activity of the human apolipoprotein E gene promoter in human astroglial cells
Du, Yansheng⋅Chen, X.⋅Wei, X.⋅Bales, KR⋅Berg, DT⋅Paul, SM⋅Farlow, Martin R⋅Maloney, B.⋅Ge, YW and Lahiri, Debomoy K
Molecular Brain Research, vol. 136, (no. 1-2), pp. 177-188, 2005. | Journal Article
 
Progress in understanding moderate to severe Alzheimer disease
Farlow, Martin
2005. | Book
 
Rivastigmine: an open-label observational study of behavioral symptoms identified as most troubling by caregivers of patients with Alzheimer's disease
Lilly, Mary and Farlow, Martin
Journal of the American Psychiatric Nurses Association (JAPNA), vol. 11, (no. 5), pp. 293, 20051001. | Journal Article
 
Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years
Farlow, Martin R and Lilly, Mary L
BMC Geriatrics, vol. 5, 2005. | Journal Article
 
Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years.
Farlow, Martin R and Lilly, Mary L
BMC geriatrics [electronic resource]. , vol. 5, (no. 1), pp. 3, 2005. | Journal Article
 
Safety and acceptability of the research lumbar puncture.
Peskind, Elaine R⋅Peskind, Elaine R⋅Riekse, Robert G⋅Riekse, Robert⋅Quinn, Joseph F⋅Quinn, Joseph F⋅Kaye, Jeff⋅Kaye, Jeffrey⋅Clark, Christopher M⋅Clark, Christopher M⋅Farlow, Martin R⋅Farlow, Martin R⋅Decarli, Charles⋅Decarli, Charles⋅Chabal, Charles⋅Chabal, Charles⋅Vavrek, Darcy⋅Vavrek, Darcy⋅Raskind, Murray A⋅Raskind, Murray⋅Galasko, Douglas and Galasko, Douglas
Alzheimer disease and associated disorders, vol. 19, (no. 4), pp. 220-5, 2005 Oct-Dec. | Journal Article
 
Safety, Tolerability, and Changes in Amyloid [beta] Concentrations After Administration of a [gamma]-Secretase Inhibitor in Volunteers
Siemers, Eric R⋅Skinner, M.⋅Dean, RA⋅Gonzales, C.⋅Satterwhite, J.⋅Farlow, Martin R⋅Ness, D. and May, PC
Clinical Neuropharmacology, vol. 28, (no. 3), pp. 126-132, 2005. | Journal Article
 
Switching From Donepezil to Rivastigmine Is Well Tolerated: Results of an Open-Label Safety and Tolerability Study.
Sadowsky, Carl H⋅Farlow, Martin R⋅Atkinson, Leone⋅Steadman, Jennifer⋅Koumaras, Barbara⋅Chen, Michael and Mirski, Dario
Primary care companion to the Journal of clinical psychiatry, vol. 7, (no. 2), pp. 43-48, 2005. | Journal Article
 
The search for disease modification in moderate to severe Alzheimer disease: a critical review of current evidence
Farlow, Martin R
Neurology, vol. 65, (no. 3), pp. S25-S30, 2005. | Journal Article
 
The use of memantine in dementia with Lewy bodies.
Sabbagh, Marwan N⋅Hake, Ann M⋅Ahmed, Sahir and Farlow, Martin R
Journal of Alzheimer's disease : JAD, vol. 7, (no. 4), pp. 285-9, 2005/Aug. | Journal Article
2004
Caffeic acid phenethyl ester prevents neonatal hypoxic-ischaemic brain injury
Wei, Xing⋅Zhao, Liming⋅Ma, Zhizhong⋅Holtzman, David M⋅Yan, Chong⋅Dodel, Richard C⋅Hampel, Harald⋅Oertel, Wolfgang H⋅Farlow, Martin R and Du, Yansheng
Brain, vol. 127, (no. 12), pp. 2629-2635, 2004. | Journal Article
 
Differential qualitative responses to rivastigmine in APOE epsilon 4 carriers and noncarriers
Farlow, Martin R⋅Lane, R.⋅Kudaravalli, S. and He, Y.
Pharmacogenomics Journal, vol. 4, (no. 5), pp. 332-335, 2004. | Journal Article
 
Impact of APOE in mild cognitive impairment.
Farlow, Martin R⋅He, Y⋅Tekin, S⋅Xu, J⋅Lane, R and Charles, Hal C
Neurology. , vol. 63, (no. 10), pp. 1898-901, 2004/Nov/23. | Journal Article
 
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.
Tariot, Pierre N⋅Farlow, Martin R⋅Grossberg, George T⋅Graham, Stephen M⋅McDonald, Scott and Gergel, Ivan
JAMA : the journal of the American Medical Association. , vol. 291, (no. 3), pp. 317-24, 2004/Jan/21. | Journal Article
 
On the horizon: pathways for drug development in Alzheimer's disease
Hake, Ann Marie and Farlow, Martin R
Clinics in Geriatric Medicine, vol. 20, (no. 1), pp. 152, 2004. | Journal Article
 
P1-063 The rate of decline in mild to moderate stage Alzheimer disease is associated with increased symptoms of depression
Hake, Ann Marie⋅Schneider, Lon S⋅Tariot, Pierre N and Farlow, Martin R
Neurobiology of Aging, vol. 25, pp. S113, 2004. | Journal Article